General Information of Drug Transporter (DT)
DT ID DTD0171 Transporter Info
Gene Name SLC25A13
Transporter Name Calcium-binding mitochondrial carrier protein Aralar2
Gene ID
10165
UniProt ID
Q9UJS0
Post-Translational Modification of This DT
Overview of SLC25A13 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-Malonylation X-Methylation X-O-glycosylation X-Oxidation X-Phosphorylation X-S-nitrosylation X-Succinylation X-Sulfoxidation X-Ubiquitination X: Amino Acid

Acetylation

  Alanine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Alanine

Modified Location

2

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC25A13 Alanine 2 has the potential to affect its expression or activity.

  Glycine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [3]

Role of PTM

Potential impacts

Modified Residue

Glycine

Modified Location

485

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC25A13 Glycine 485 has the potential to affect its expression or activity.

  Lysine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

23

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC25A13 Lysine 23 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A13 [4]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

251

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC25A13 Lysine 251 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A13 [6]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

379

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC25A13 Lysine 379 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A13 [7]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

405

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC25A13 Lysine 405 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC25A13 [4] , [8]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

484

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC25A13 Lysine 484 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC25A13 [4]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

662

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC25A13 Lysine 662 has the potential to affect its expression or activity.

Malonylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [9]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

580

Experimental Method

Co-Immunoprecipitation

Detailed Description

Malonylation at SLC25A13 Lysine 580 has the potential to affect its expression or activity.

Methylation

  Lysine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [6]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

379

Experimental Method

Co-Immunoprecipitation

Detailed Description

Methylation at SLC25A13 Lysine 379 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A13 [10]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

453

Experimental Method

Co-Immunoprecipitation

Detailed Description

Methylation at SLC25A13 Lysine 453 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A13 [11]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

484

Experimental Method

Co-Immunoprecipitation

Detailed Description

Methylation at SLC25A13 Lysine 484 has the potential to affect its expression or activity.

O-glycosylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [12] , [13]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

361

Experimental Method

Co-Immunoprecipitation

Detailed Description

O-linked Glycosylation at SLC25A13 Serine 361 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A13 [12] , [13]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

619

Experimental Method

Co-Immunoprecipitation

Detailed Description

O-linked Glycosylation at SLC25A13 Serine 619 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A13 [12] , [13]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

625

Experimental Method

Co-Immunoprecipitation

Detailed Description

O-linked Glycosylation at SLC25A13 Serine 625 has the potential to affect its expression or activity.

Oxidation

  Cystine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [14]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

202

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC25A13 Cystine 202 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A13 [14]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

377

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC25A13 Cystine 377 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A13 [14]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

437

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC25A13 Cystine 437 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A13 [14]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

503

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC25A13 Cystine 503 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC25A13 [15]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

565

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC25A13 Cystine 565 has the potential to affect its expression or activity.

Phosphorylation

  Leucine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [16]

Role of PTM

Potential impacts

Modified Residue

Leucine

Modified Location

658

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Leucine 658 has the potential to affect its expression or activity.

  Serine

        17 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [17]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

26

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 26 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A13 [17]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

36

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 36 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A13 [18]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

51

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 51 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A13 [18] , [19]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

238

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 238 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC25A13 [18]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

314

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 314 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC25A13 [20]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

361

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 361 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC25A13 [20]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

364

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 364 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC25A13 [21] , [22]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

469

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 469 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC25A13 [21] , [22]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

472

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 472 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC25A13 [23]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

510

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 510 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence SLC25A13 [23]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

519

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 519 has the potential to affect its expression or activity.

  PTM Phenomenon 12

Have the potential to influence SLC25A13 [23]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

522

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 522 has the potential to affect its expression or activity.

  PTM Phenomenon 13

Have the potential to influence SLC25A13 [23]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

536

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 536 has the potential to affect its expression or activity.

  PTM Phenomenon 14

Have the potential to influence SLC25A13 [24]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

619

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 619 has the potential to affect its expression or activity.

  PTM Phenomenon 15

Have the potential to influence SLC25A13 [20] , [25]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

664

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 664 has the potential to affect its expression or activity.

  PTM Phenomenon 16

Have the potential to influence SLC25A13 [20] , [26]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

666

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 666 has the potential to affect its expression or activity.

  PTM Phenomenon 17

Have the potential to influence SLC25A13 [20] , [27]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

668

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Serine 668 has the potential to affect its expression or activity.

  Threonine

        11 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [28] , [29]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

9

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Threonine 9 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A13 [23]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

68

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Threonine 68 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A13 [19] , [30]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

239

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Threonine 239 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A13 [19] , [30]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

243

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Threonine 243 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC25A13 [31]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

250

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Threonine 250 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC25A13 [20]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

362

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Threonine 362 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC25A13 [22] , [32]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

463

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Threonine 463 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC25A13 [22]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

464

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Threonine 464 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC25A13 [23]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

539

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Threonine 539 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC25A13 [33]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

599

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Threonine 599 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence SLC25A13 [20] , [25]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

667

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Threonine 667 has the potential to affect its expression or activity.

  Tyrosine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [30]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

237

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Tyrosine 237 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A13 [33]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

600

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Tyrosine 600 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A13 [16]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

657

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Tyrosine 657 has the potential to affect its expression or activity.

  Valine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [16]

Role of PTM

Potential impacts

Modified Residue

Valine

Modified Location

665

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A13 Valine 665 has the potential to affect its expression or activity.

S-nitrosylation

  Cystine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [34]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

377

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-nitrosylation (-SNO) at SLC25A13 Cystine 377 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A13 [35]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

503

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-nitrosylation (-SNO) at SLC25A13 Cystine 503 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A13 [34]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

565

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-nitrosylation (-SNO) at SLC25A13 Cystine 565 has the potential to affect its expression or activity.

Succinylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [3]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

484

Experimental Method

Co-Immunoprecipitation

Detailed Description

Succinylation at SLC25A13 Lysine 484 has the potential to affect its expression or activity.

Sulfoxidation

  Methionine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [36]

Role of PTM

Potential impacts

Modified Residue

Methionine

Modified Location

267

Experimental Method

Co-Immunoprecipitation

Detailed Description

Sulfoxidation at SLC25A13 Methionine 267 has the potential to affect its expression or activity.

Ubiquitination

  Alanine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Alanine

Modified Location

488

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Alanine 488 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Alanine

Modified Location

498

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Alanine 498 has the potential to affect its expression or activity.

  Asparticacid

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Asparticacid

Modified Location

350

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Asparticacid 350 has the potential to affect its expression or activity.

  Glutamicacid

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Glutamicacid

Modified Location

200

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Glutamicacid 200 has the potential to affect its expression or activity.

  Glycine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Glycine

Modified Location

481

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Glycine 481 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A13 [3] , [37]

Role of PTM

Potential impacts

Modified Residue

Glycine

Modified Location

485

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Glycine 485 has the potential to affect its expression or activity.

  Histidine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Histidine

Modified Location

124

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Histidine 124 has the potential to affect its expression or activity.

  Leucine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Leucine

Modified Location

203

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Leucine 203 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Leucine

Modified Location

409

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Leucine 409 has the potential to affect its expression or activity.

  Lysine

        11 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [38]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

23

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Lysine 23 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

69

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Lysine 69 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A13 [38]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

104

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Lysine 104 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC25A13 [38]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

251

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Lysine 251 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

353

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Lysine 353 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC25A13 [39]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

379

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Lysine 379 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC25A13 [39]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

380

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Lysine 380 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

405

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Lysine 405 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

408

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Lysine 408 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

484

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Lysine 484 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

487

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Lysine 487 has the potential to affect its expression or activity.

  Phenylalanine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Phenylalanine

Modified Location

419

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Phenylalanine 419 has the potential to affect its expression or activity.

  Proline

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Proline

Modified Location

495

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Proline 495 has the potential to affect its expression or activity.

  Serine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

364

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Serine 364 has the potential to affect its expression or activity.

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A13 [37]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

354

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC25A13 Threonine 354 has the potential to affect its expression or activity.
References
1 N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54.
2 N-terminome analysis of the human mitochondrial proteome. Proteomics. 2015 Jul;15(14):2519-24.
3 Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009 Aug 14;325(5942):834-40.
4 Quantitative Proteomic Atlas of Ubiquitination and Acetylation in the DNA Damage Response. Mol Cell. 2015 Sep 3;59(5):867-81.
5 Suberoylanilide hydroxamic acid treatment reveals crosstalks among proteome, ubiquitylome and acetylome in non-small cell lung cancer A549 cell line. Sci Rep. 2015 Mar 31;5:9520.
6 Circadian and seasonal variation in human preovulatory follicular fluid melatonin concentration. J Clin Endocrinol Metab. 1990 Aug;71(2):492-6.
7 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: CMC2_HUMAN)
8 Regulation of cellular metabolism by protein lysine acetylation. Science. 2010 Feb 19;327(5968):1000-4.
9 Proteomic and Biochemical Studies of Lysine Malonylation Suggest Its Malonic Aciduria-associated Regulatory Role in Mitochondrial Function and Fatty Acid Oxidation. Mol Cell Proteomics. 2015 Nov;14(11):3056-71.
10 Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol Cell Proteomics. 2014 Jan;13(1):372-87.
11 Clinical applications of the enzyme labeled antibody method. Immunoperoxidase methods in diagnostic histopathology. J Histochem Cytochem. 1979 Aug;27(8):1140-7.
12 A triarylphosphine-trimethylpiperidine reagent for the one-step derivatization and enrichment of protein post-translational modifications and identification by mass spectrometry. Chem Commun (Camb). 2018 Dec 6;54(98):13790-13793.
13 Combinatorial regulation of hepatic cytoplasmic signaling and nuclear transcriptional events by the OGT/REV-ERBalpha complex. Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11033-E11042.
14 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
15 Identifying Functional Cysteine Residues in the Mitochondria. ACS Chem Biol. 2017 Apr 21;12(4):947-957.
16 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
17 The Plk1-dependent phosphoproteome of the early mitotic spindle. Mol Cell Proteomics. 2011 Jan;10(1):M110.004457.
18 An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62.
19 Global Phosphoproteomic Analysis of Human Skeletal Muscle Reveals a Network of Exercise-Regulated Kinases and AMPK Substrates. Cell Metab. 2015 Nov 3;22(5):922-35.
20 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
21 Feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentation. J Proteome Res. 2010 Dec 3;9(12):6786-94.
22 Opposite Electron-Transfer Dissociation and Higher-Energy Collisional Dissociation Fragmentation Characteristics of Proteolytic K/R(X)n and (X)nK/R Peptides Provide Benefits for Peptide Sequencing in Proteomics and Phosphoproteomics. J Proteome Res. 2017 Feb 3;16(2):852-861.
23 Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
24 Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
25 Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
26 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
27 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
28 Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal. 2013 Mar 26;6(268):rs6.
29 Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets. PLoS One. 2014 Mar 26;9(3):e90948.
30 System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal. 2011 Mar 15;4(164):rs3.
31 Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
32 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
33 Improve the coverage for the analysis of phosphoproteome of HeLa cells by a tandem digestion approach. J Proteome Res. 2012 May 4;11(5):2828-37.
34 Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine Subpopulations: A Method to Maximize S-Nitrosylation Detection. Circ Res. 2015 Oct 23;117(10):846-57.
35 Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat Commun. 2019 May 16;10(1):2195.
36 Redox-based reagents for chemoselective methionine bioconjugation. Science. 2017 Feb 10;355(6325):597-602.
37 A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
38 UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
39 Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.